Share the Science: Potential New Umbilical Cord Derived Cellular Therapies

Save the Cord Foundation and WellSky are proud to welcome Dr. Anthony Filiano from the Marcus Center for Cellular Cures (MC3) at Duke University, as our featured speaker for our next edition of Share the Science on May 27th, 2020. Join us to hear Dr. Filiano present his research using umbilical cord-derived cell therapies to target neuroinflammation. Recording available.
​
Share the Science is a free webinar series focused on the cord blood industry and the latest research in this field.  As always, we invite both health professionals and the general public to join us for this unique online educational series. Learn more about this exciting educational series here.

Recent research using cord blood has demonstrated the efficacy of using cord-blood derived components to promote myelination and increase function in neurological conditions such as multiple sclerosis, autism spectrum disorder, and aging. For our next Share the Science webinar, Dr. Anthony Filiano will speak about the exciting research he and his colleagues are pursuing in this area. 

​Dr. Filiano and his colleagues at the Marcus Center for Cellular Cures (Duke University) are interested in understanding the complex interactions between the immune system and nervous system with the intent to uncover novel therapeutic targets to combat diseases such as autism spectrum disorder. In particular, Dr. Filiano's work is focused on how cord-blood derived cells and products can be used to promote healthy brain function and alleviate behavioral dysfunction in these devastating neurological conditions.

In this Share the Science webinar, Dr. Filiano will discuss two investigational cell therapies for inflammatory disease:

1. Potential use of cord blood monocytes as therapies. Dr. Filiano will highlight approaches and strategies taken at the Marcus Center for Cellular Cures at Duke to identify how cord blood monocytes can be used to treat diseases such as leukodystrophies, cerebral palsy, and multiple sclerosis.
2. Potential use of cord-tissue-derived mesenchymal stromal cells to reprogram the immune system. Examine the novel mechanisms uncovered through research at the Marcus Center that suggest cord-tissue-derived mesenchymal stromal cells can reprogram the immune system.

​
Both of these studies point to exciting developments in the use of cord blood and cord tissue. Equally, these studies bring hope to many patients around the world who are looking for treatments to complex conditions often considered untreatable.

​SHARE THE SCIENCE
with
Dr. Anthony Filiano

Principle Investigator & Assistant Professor of Neurosurgery
​Marcus Center for Cellular Cures (MC3) at Duke University

"Targeting Neuroinflammation with Umbilical Cord-Derived Cell Therapies"

Free webinar.  Open to the public.
​
Wednesday, March 27th - 2pm Eastern Time/11am Pacific Time

RECORDING NOW AVAILABLE

Watch Share the Science: Dr. Filiano

---

About the speaker

Dr. Anthony Filiano is an Assistant Professor of Neurosurgery at the Marcus Center for Cellular Cures (MC3) at Duke University. Dr. Filiano’s research looks at how cord blood- and cord tissue-derived cell therapies can be used to treat inflammatory disease, in particular inflammatory disorders of the brain. The Filiano Lab is interested in understanding the complex interactions between the immune system and nervous system with the intent to uncover novel therapeutic targets to combat diseases. Dr. Filiano received his education and training from the University of Alabama at Birmingham, D.Phil, and the University of Virginia, where he was a Hartwell Fellow.

---

We wish to thank Dr. Filiano for volunteering his time to speak on
Share the Science and sharing his valuable insight using umbilical
​cord-derived cell therapies to target neuroinflammation.

​
We also wish to also thank our generous sponsor and partner for this event,
WellSky Health, who continue to support cord blood
education through our “Share the Science” series.